iSAFE™ NIPT Assay for Trisomy 21, Trisomy 18, Trisomy 13 Detection, Fetal Fraction, and Gender Determination on naica® system (Stilla Technologies)

iSAFE™ NIPT Assay for Trisomy 21, Trisomy 18, Trisomy 13 Detection, Fetal Fraction, and Gender Determination on naica® system (Stilla Technologies)

The Atila iSAFE™ Non-Invasive Prenatal Test (NIPT) Assay screens for aneuploidy of chromosomes 21, 18, and 13 in singleton pregnancies. The assay combines Atila’s extreme multiplex PCR technology and applies Crystal Digital PCR™ technology on the 6-color naica® system to accurately quantify the copy numbers of chromosome 21, 18, and 13 in maternal blood cell-free DNA (cfDNA).

Features

• Highly multiplexed PCR: Enables simultaneous quantification of the chromosome 21, 18, 13, and 1, and the fetal fraction.
• Simple procedures: Direct Digital PCR amplification on purified cfDNA
• Simple data analysis: No complicated bioinformatics required
• The naica® system features ready-to-use digital PCR reagents and chip consumables for optimized throughput and flexible sensitivity. Easy-to-use instrument operation and intuitive software analysis enable fast time-to-results. Learn more about the naica® system workflow at naica® System Workflow | Stilla Technologies.

*  This products is for research use only.